CME Group Inc.
CMENASDAQFinancial Services● Active
$252.03
$-5.37(-2.09%)
Market Cap$91.3B
P/E Ratio—
52W High$329.16
52W Low$244.56
CME Group Inc. (CME) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CME · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 22, 2026EPS Actual
$3.36
Est. $3.34 · +0.6%
Revenue
$1.88B
Est. $1.87B · +0.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 22, 2026
After Market Close
🔥 11-Quarter EPS Beat Streak
CME reports quarterly as a NASDAQ-listed Financial - Data & Stock Exchanges company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 22, 2026 | $3.01 | — | — | — | $1.72B | — |
| — Q2 FY2026 | Apr 22, 2026 | $3.34 | $3.36 | +0.6% | $1.88B | $1.87B | +0.3% |
| — Q1 FY2026 | Feb 4, 2026 | $2.75 | $2.77 | +0.7% | $1.65B | $1.65B | +0.1% |
| ▲ Q4 FY2025 | Oct 22, 2025 | $2.63 | $2.68 | +1.9% | $1.54B | $1.53B | +0.5% |
| ▲ Q3 FY2025 | Jul 23, 2025 | $2.91 | $2.96 | +1.7% | $1.69B | $1.69B | +0.4% |
| — Q2 FY2025 | Apr 23, 2025 | $2.80 | $2.80 | +0.0% | $1.64B | $1.64B | -0.1% |
| ▲ Q1 FY2025 | Feb 12, 2025 | $2.46 | $2.52 | +2.4% | $1.53B | $1.51B | +0.7% |
| — Q4 FY2024 | Oct 23, 2024 | $2.66 | $2.68 | +0.8% | $1.58B | $1.59B | -0.3% |
Q3 FY2026
Jul 22, 2026
EPS Actual
—
EPS Est.
$3.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 22, 2026
EPS Actual
$3.36
EPS Est.
$3.34
EPS Surpr.
+0.6%
Revenue
$1.88B
Q1 FY2026
Feb 4, 2026
EPS Actual
$2.77
EPS Est.
$2.75
EPS Surpr.
+0.7%
Revenue
$1.65B
Q4 FY2025
Oct 22, 2025Beat
EPS Actual
$2.68
EPS Est.
$2.63
EPS Surpr.
+1.9%
Revenue
$1.54B
Q3 FY2025
Jul 23, 2025Beat
EPS Actual
$2.96
EPS Est.
$2.91
EPS Surpr.
+1.7%
Revenue
$1.69B
Q2 FY2025
Apr 23, 2025
EPS Actual
$2.80
EPS Est.
$2.80
EPS Surpr.
+0.0%
Revenue
$1.64B
Q1 FY2025
Feb 12, 2025Beat
EPS Actual
$2.52
EPS Est.
$2.46
EPS Surpr.
+2.4%
Revenue
$1.53B
Q4 FY2024
Oct 23, 2024
EPS Actual
$2.68
EPS Est.
$2.66
EPS Surpr.
+0.8%
Revenue
$1.58B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2030 | $3.22 | $3.37 | $3.54 | 4 |
| Q3 FY2030 | $3.35 | $3.50 | $3.68 | 4 |
| Q2 FY2030 | $3.42 | $3.58 | $3.76 | 4 |
| Q1 FY2030 | $3.49 | $3.65 | $3.83 | 4 |
| Q4 FY2029 | $3.31 | $3.46 | $3.63 | 4 |
| Q3 FY2029 | $3.44 | $3.60 | $3.78 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2030 | $2.0B | $2.1B | $2.1B | 6 |
| Q3 FY2030 | $2.0B | $2.1B | $2.2B | 6 |
| Q2 FY2030 | $2.0B | $2.1B | $2.2B | 3 |
| Q1 FY2030 | $2.1B | $2.1B | $2.2B | 3 |
| Q4 FY2029 | $1.9B | $2.0B | $2.1B | 3 |
| Q3 FY2029 | $1.9B | $2.0B | $2.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 22, 2026 | +0.6% | $284.40 | $285.71 | +0.46% |
| ▲ Q1 FY2026 | Feb 4, 2026 | +0.7% | $293.07 | $294.62 | +0.53% |
| ▲ Q4 FY2025 | Oct 22, 2025 | +1.9% | $268.61 | $267.81 | -0.30% |
| ▲ Q3 FY2025 | Jul 23, 2025 | +1.7% | $274.64 | $276.48 | +0.67% |
| ▲ Q2 FY2025 | Apr 23, 2025 | +0.0% | $265.56 | $261.48 | -1.54% |
| ▲ Q1 FY2025 | Feb 12, 2025 | +2.4% | $241.74 | $248.96 | +2.99% |
| ▲ Q4 FY2024 | Oct 23, 2024 | +0.8% | $226.17 | $227.14 | +0.43% |
| ▲ Q3 FY2024 | Jul 24, 2024 | +1.2% | $197.44 | $197.25 | -0.10% |
Q2 FY2026+0.46%
Report Date
Apr 22, 2026
EPS Beat/Miss
+0.6%
Price Before
$284.40
Price After
$285.71
Q1 FY2026+0.53%
Report Date
Feb 4, 2026
EPS Beat/Miss
+0.7%
Price Before
$293.07
Price After
$294.62
Q4 FY2025-0.30%
Report Date
Oct 22, 2025
EPS Beat/Miss
+1.9%
Price Before
$268.61
Price After
$267.81
Q3 FY2025+0.67%
Report Date
Jul 23, 2025
EPS Beat/Miss
+1.7%
Price Before
$274.64
Price After
$276.48
Q2 FY2025-1.54%
Report Date
Apr 23, 2025
EPS Beat/Miss
+0.0%
Price Before
$265.56
Price After
$261.48
Q1 FY2025+2.99%
Report Date
Feb 12, 2025
EPS Beat/Miss
+2.4%
Price Before
$241.74
Price After
$248.96
Q4 FY2024+0.43%
Report Date
Oct 23, 2024
EPS Beat/Miss
+0.8%
Price Before
$226.17
Price After
$227.14
Q3 FY2024-0.10%
Report Date
Jul 24, 2024
EPS Beat/Miss
+1.2%
Price Before
$197.44
Price After
$197.25
Avg Beat Reaction+0.39%
Beat Rate8 / 8 quarters
Largest Move+2.99% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CME ends December
CME Group Inc. (CME) most recently reported earnings on April 22, 2026 for Q2 FY2026, posting EPS of $3.36 (in line with the analyst consensus of $3.34). CME has beaten EPS estimates for 11 consecutive quarters. The next CME earnings date is expected around September 1, 2026.
Each quarter, investors track CME earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CME revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CME's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CME earnings · 4 questionsCME Group Inc.'s next earnings report is expected around September 1, 2026. CME typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CME historically reports after market close (AMC).
CME earnings datewhen is CME earningsCME next earnings datewhen does CME report earningsCME earnings calendar
▸ Source: FMP · CME Group Inc. SEC filings · US GAAP · CME Group Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026